Stem Cell Company Stocks 2/7/09: The Week That Was

Right now, trading Stem Cells stocks is the number one place to make money in the stock market. It has been a little over two weeks now since Geron Corp's ground breaking announcement on 1/23/09. In classic bull market fashion, the share price of every publicly traded Stem Cell company that we have followed since then remains significantly higher. After such explosive share price movement prior to last week, a substantial pullback would have been expected. However, the fact that most of the gains held is a testament to the strength of this sector. See below for our company list. Please note that Vitro Diagnostics (VODG.OB) was remove from due to a lack of volume. It has been replaced with BioTime, Inc. (BTIM). BioTime is interesting because of one of its subsidiaries called Embryome Sciences, Inc. It happens to be one of the lesser known stocks that deal directly with embryonic stem cells.

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Current Price: $2.86; Up 99%
Aastrom Biosciences (ASTM) = Current Price: $0.64; Up 24%
BioTime, Inc. (BTIM) = Current Price: $2.45; Up 17%
Celgene Corp (CELG) = Current Price: $55.35; Up 13%
Geron Corp (GERN) = Current Price: $8.05; Up 55%
ThermoGenesis (KOOL) = Current Price: $0.77; Up 42%
Osiris Therapeutics (OSIR) = Current Price: $20.71; Up 10%
StemCell Inc. (STEM) = Current Price: $2.52; Up 17%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.PK) = Current Price: $0.19; Up 58%
Athersys Inc. (ATHX) = Current Price: $1.10; Up 62%
Brainstorm Cell Therapeutics (BCLI.OB) = Current Price: $0.13; Up 25%
Bioheart Inc. (BHRT) = Current Price: Current Price: $0.99; Up 25%
Cord Blood America Inc. (CBAI.OB) = Current Price: $0.0146; Up 284%
Cryo-Cell Intl (CCEL.OB) = Current Price: $0.56; Up 22%
Neuralstem (CUR) = Current Price: $1.55; Up 8%
International Stem Cell (ISCO.OB) = CurrentPrice: $0.42; Up 45%
LifeStem International (LSTM) = Current Price: $0.130; Up 233%
MultiCell Technologies (MCET.OB) = Current Price: $0.022; Up 412%
Pluristem Therapeutics (PSTI) = Current Price: $1.35; Up 112%
Stem Cell Therapy Intl (SCII) = Current Price: $0.10; Up 100%
Stem Cell Innovations (SCLL.PK) = Current Price: $0.015; Up 109%

Notable Moves the Week of 2/2/09 - 2/6/09

Last Week's Top Performer: ARIA
- Up every day last week for a 71% total gain; Speculation is that it is an "Earnings Call" run up. Earnings are scheduled to be released on 2/12/09

Last Week's Worst Performer: PSTI
- Down 4 out of 5 days for a 25% total loss; Pulled back after company sold additional shares

Cord Blood America (CBAI.OB), which provides cord blood stem cell banking services and MultiCell Technologies (MCET.OB) were notable mostly in that they remained fairly flat for the week. Despite many critics declaring these two stocks as being nothing more than "pump and dumps", they appear to be holding up pretty well.

Possible Catalyst for Next Week

- Further progress in Congress regarding new stem cell legislation
- Senate passes the Stimulus Package
- Bio CEO & Investor Conference begins Monday February 9, 2009; Several of the companies that we are following have their CEO's presenting; See link for the entire list BIO CEO & Investor Conference

Don't forget to check back frequently to for all your Stem Cell stock "homework". I think the upcoming article on determining when to exit a position in a hot sector will be eye opening. So, check back soon!

No comments:

Post a Comment